Cassia Cearley, Chief Business Officer at Icosavax, Inc. (ICVX), sold 1,812 shares at $7.11 ($12K) on 2022-07-29, disclosed to the SEC on 2022-08-02.
Scheduled sale ($12k) by Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.11 | 391 | $3K | 22.7% |
| 2 | $6.64 | 1,118 | $7K | 60.7% |
| 3 | $6.70 | 303 | $2K | 16.6% |
| Total | $6.75 avg | 1,812 | $12K | 100% |
| Filing → |
| ICVX | SELL | 2023-08-01 | $17K | — | Filing → |
| ICVX | SELL | 2023-05-25 | $100K | — | Filing → |
| ICVX | SELL | 2023-03-08 | $39K | — | Filing → |